Disclosures for "Phase 1 Asian PK Study of ABBV-CLS-7262, an eIF2B Activator Being Developed as a Potential Treatment for Amyotrophic Lateral Sclerosis and Vanishing White Matter Disease"
-
Dr. Han has received personal compensation for serving as an employee of AbbVie.
-
Dr. Malik has received personal compensation for serving as an employee of AbbVie. Dr. Malik has received personal compensation for serving as an employee of Calico Life Sciences.
-
Dr. Huang has received personal compensation for serving as an employee of AbbVie.
-
Dr. Boiser has received personal compensation for serving as an employee of AbbVie. Dr. Boiser has stock in AbbVie.
-
Dr. Jeong has received personal compensation for serving as an employee of AbbVie. An immediate family member of Dr. Jeong has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Stryker. Dr. Jeong has stock in AbbVie.
-
Mrs. Siovitz has stock in AbbVie.
-
Sven Stodtmann has received personal compensation for serving as an employee of AbbVie.
-
Dr. Cho has received personal compensation for serving as an employee of Calico. Dr. Cho has stock in Roche.
-
Dr. Rosebraugh has received personal compensation for serving as an employee of AbbVie Inc. Dr. Rosebraugh has stock in AbbVie Inc..